Development of the G-Risk scoring system utilizing inflammatory and tumor biomarkers to improve prognostic accuracy in gastric cancer patients without lymphovascular invasion
The G-Risk score was successfully developed and validated as a reliable prognostic tool for gastric cancer patients without LVI. Its clinical implementation offers enhanced precision in assessing prognostic risk, facilitating personalized treatment planning, improving therapeutic outcomes, and reducing unnecessary medical interventions.
Authors
- Boran Xu
- Eryu Liu
- Huannan Guo
- Chunfeng Li (ORCID: https://orcid.org/0000-0003-0075-6900)
- Lili Lv (ORCID: https://orcid.org/0009-0001-6538-2156)
- Lei Shi (ORCID: https://orcid.org/0000-0002-6510-7904)
Institutions
- Harbin Medical University (CN)
- Third Affiliated Hospital of Harbin Medical University (CN)
- Qinhuangdao Glass Industry Research and Design Institute (China) (CN)
Publication Details
- Journal
- European journal of medical research
- Published
- 2025-04-19
- DOI
- https://doi.org/10.1186/s40001-025-02540-4
- Primary Topic
- Gastric Cancer Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China